Pharmaceuticals: IPM: 11.5% value and 5% unit growth in Junâ25
As per IQVIA, IPM saw a strong growth for Junâ25 at 11.5% YoY (vs 7% in Aprâ25 and FY25, +7% YoY in Junâ24) with 5% YoY growth in units
191 Views
Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
224 Views
HSIE Results Daily: DLF, Torrent Pharma, Dixon Technologies, Zydus Lifesciences...
DLF reported a stable quarter with pre-sales of INR 20.3bn (+39.1%/-83.2% YoY/QoQ), largely on the back of sustenance sales from recently-launched...
215 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an âExecutive Orderâ (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
163 Views
Pharmaceuticals: Lupin/Zydus lost Myrbetriq patent case in district court
Lupin and Zydus received unfavourable opinion in Mirabegron (gMyrbetriq) patent litigation (against Astellas Pharma) from the District court of...
701 Views